Document is current
Any future updates will be listed below
-
Authors
Hattab, Moath
Shakhshir, Mohammed
Khalil, Carmel
Mletat, Raw’a
Rabi, Razan
Yassin, Raya
Hejaz, Malek
Hajhamad, Mohammed M.
-
Funding
Funding for this research was provided by:
Al-Ram pharmaceutical company
- License Information
-
More Information
Article History
Received: 15 September 2025
Accepted: 15 December 2025
First Online: 18 December 2025
Declarations
:
: All aspects of the study protocol, including access to and use of the patient’s clinical information, were authorized by the Institutional Review Boards (IRB) of the Palestinian Ministry of Health (Nablus, Palestine) and was adherent to local regulations and with the 1964 Declaration of Helsinki and its later amendment. All participants were adults (≥ 18 years) and provided written informed consent prior to enrollment.
: Written informed consent was obtained from the patient for the participation in and publication of this clinical trial. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
: The authors declare no competing interests.
